Out-of-pocket medical costs in relation to resection of colorectal liver metastases in the Australian healthcare system
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-025-09669-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Nazim Bhimani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Upper Gastrointestinal Surgical Unit, Clinical Administration 8 A, Acute Services Building, Royal North Shore Hospital, St Leonards, NSW 2065, Austra…. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Health Expenditures, Hepatectomy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sydney.
Abstract (Originalsprache)
Purpose
The cost of treating colorectal liver metastases (CRLM) places a financial burden on the healthcare system; however, there is limited research on the out-of-pocket (OOP) costs to patients. This study aimed to assess the direct medical OOP costs on patients who undergo liver resection for CRLM and evaluate their financial worry, stress, and difficulty.
Methods
This was a retrospective cohort analysis of the OOP costs for patients who underwent potentially curative resection of CRLM in Sydney, Australia, between 2010 and June 2021. These costs were determined in Australian dollars from the diagnosis of liver metastases to their last follow-up. Patients completed a series of questions relating to financial worry, stress, and difficulty.
Results
In total, 121 patients underwent liver resection, of which 85 were alive at a median follow-up of 5.3 years (1.8–13.7). There was a 59% response rate (50/85). Specialist consultation costs varied, with a median OOP cost of $393.35. Liver surgical treatment incurred the highest median OOP cost of $1011.29 (range $0–$7246.54). There were minimal OOP costs for chemotherapy and no OOP costs for radiation oncology. Most patients were not worried about the OOP costs (60%) and said there was no impact on their ability to make ends meet (64%) or had no effect on their finances (56%).
Conclusion
This study demonstrates that patients who undergo liver resection for CRLM and have long-term survival have moderate OOP costs. Most patients were not worried or stressed with the amount they had to pay OOP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Upper Gastrointestinal Surgical Unit, Clinical Administration 8 A, Acute Services Building, Royal North Shore Hospital, St Leonards, NSW 2065, Australia. nazim.bhimani@health.nsw.gov.au.
- Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. nazim.bhimani@health.nsw.gov.au.
- Colorectal Surgical Department, Royal North Shore Hospital, St Leonards, NSW, Australia.
- Medical Oncology Department, Royal North Shore Hospital, St Leonards, NSW, Australia.
- GenesisCare, North Shore Health Hub, St Leonards, NSW, Australia.
- Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Förderung
- University of Sydney
Zitieren
APA
Bhimani, N., Seton, R., Chan, D., Dieng, M., Kelly, P. J., & Hugh, T. J. (2025). Out-of-pocket medical costs in relation to resection of colorectal liver metastases in the Australian healthcare system. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09669-2
Vancouver
Bhimani N, Seton R, Chan D, Dieng M, Kelly PJ, Hugh TJ. Out-of-pocket medical costs in relation to resection of colorectal liver metastases in the Australian healthcare system. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09669-2
BibTeX
@article{Bhimani2025,
author = {Bhimani, Nazim and Seton, Rebecca and Chan, David and Dieng, Mbathio and Kelly, Patrick J and Hugh, Thomas J},
title = {Out-of-pocket medical costs in relation to resection of colorectal liver metastases in the Australian healthcare system},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-025-09669-2}
}
EUVIMED